On Demand


Free
Keyword Filter

Sessions

Chewing the Fat: Panel and Discussion about Autophagy and Future Directions of the Autophagy Field


Keystone Symposia ePanel:

Chewing the Fat: Panel and Discussion about Autophagy and Future Directions of the Autophagy Field

This panel discussion occurred during the "Autophagy: Molecular and Physiological Mechanisms" Keystone Symposia conference in Whistler, British Columbia, Canada on June 7, 2016. Eric Baehrecke, Ana Maria Cuervo, Vojo Deretic and Leon Murphy met to discuss their interests in autophagy. Topics included some history, current and future areas of research focus, controversies, and speculation about the future directions of the autophagy field.


___

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org



Moderator(s): Panelist(s):
Free

Autophagy: Controversies, Challenges & Opportunities


Keystone Symposia ePanel:

Autophagy: Controversies, Challenges & Opportunities


Recorded during Keystone Symposia meeting: Autophagy [E615]

Date: June 19 - 24, 2015

Location: Beaver Run Resort, Breckenridge, CO


___


About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org



Moderator(s): Panelist(s):
Free

At the edge of survival: Genetic associations for cell death in pemphigus foliaceus


Speaker(s):

Migration-induced shattering due to DOCK8-deficiancy causes a type-2 biased helper T cell response


Speaker(s):

Targeting Cell Death Pathways to Improve Anti-Cancer Therapies


Speaker(s):

Development of CAR-T Cell Therapies for Leukemia


Speaker(s):

Determinants of viral control following ART-interruption in SIV-infected macaques


Keystone Symposia SciTalks:

Determinants of viral control following ART-interruption in SIV-infected macaques


Recorded: March 20 - 24, 2016

Keystone Symposia meeting: HIV Vaccines [X8]

Location: Resort at Squaw Creek, Olympic Valley, CA


d43ea265961fbf2481a9fbb3c395ae5b.png


___

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org



Speaker(s):
  • Luca Micci, PhD, Yerkes National Primate Research Center (YNPRC), Emory University
Free

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention & Therapy of HIV-1 Clade C Infection


Keystone Symposia SciTalks:

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention & Therapy of HIV-1 Clade C Infection


Recorded: March 20 - 24, 2016

Keystone Symposia meeting: HIV Vaccines [X8]

Location: Resort at Squaw Creek, Olympic Valley, CA


a5185dcd0dd90f06d35754b33530af6c.png



___

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org



Speaker(s):
Free

A novel conserved-region T-cell mosaic vaccine with very globale coverage of HIV-1 variants is recognized by protective responses in chronic untreated infection


Keystone Symposia SciTalks:

A novel conserved-region T-cell mosaic vaccine with very globale coverage of HIV-1 variants is recognized by protective responses in chronic untreated infection


Recorded: March 20 - 24, 2016

Keystone Symposia meeting: HIV Vaccines [X8]

Location: Resort at Squaw Creek, Olympic Valley, CA


c4e08c8e8923613e37046f6b05573d3a.png


___

Copyright Keystone Symposia, 2017. All rights reserved.

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org



Speaker(s):
Free

The Genome Editing Revolution - Translating Genome Editing Technologies into Human Therapies


Keystone Symposia Live Panel:
The Genome Editing Revolution: Translating Genome Editing Technologies into Human Therapies


Recent advances in genome editing nucleases have led to their broader application in biomedical research and dramatically accelerated efforts to develop therapeutics based on this technology. In this dynamic, interactive panel event, experts in genome editing and gene therapy from academia and industry will discuss the following topics and others relevant to clinical translation of the technology:

  • What are the most important recent basic science and technological advances and biggest impacts in the field of genome editing that will substantially advance the prospects of gene-based therapy?
  • How can the experiences of the gene therapy field inform the development of genome editing therapeutics?
  • What are the risks and biggest obstacles that must be minimized and overcome to successfully translate genome editing into human therapeutics?
  • Which diseases are the most promising candidates to benefit from genome editing therapies?
  • What impact, if any, has the CRISPR IP dispute had on developing gene-based therapeutics?


ab60130c705a512e401f8efd30e5b59f.png
___

Copyright Keystone Symposia, 2017. All rights reserved.

About Keystone Symposia:
Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org



Moderator(s): Panelist(s):
Free
Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
Number of hours attended:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content